Pharmacological properties of faster‐acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double‐blind, crossover trial

AIM: To evaluate the pharmacological characteristics of faster‐acting insulin aspart (faster aspart) compared with insulin aspart (IAsp) during continuous subcutaneous insulin infusion (CSII). METHODS: In this randomized, double‐blind, crossover trial, 48 men and women aged 18 to 64 years with type...

Descripción completa

Detalles Bibliográficos
Autores principales: Heise, Tim, Zijlstra, Eric, Nosek, Leszek, Rikte, Tord, Haahr, Hanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299522/
https://www.ncbi.nlm.nih.gov/pubmed/27709762
http://dx.doi.org/10.1111/dom.12803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299522/
https://www.ncbi.nlm.nih.gov/pubmed/27709762
http://dx.doi.org/10.1111/dom.12803

Ejemplares similares